Search
for
Sort by
Research 511–540 of 1000+
- Re‐Innovation in Clinical Trial Designs Based on Precision Therapy
- Clinicopathological Features and Pathogenesis of Thymoma Complicated with Alopecia Areata: A Multicenter, Matched Case Analysis
- Editors' Picks
- Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers
- Recent advances on skin‐resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti‐aging and cancer therapies
- Kinase Inhibition with BAY 43–9006 in Renal Cell Carcinoma
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- Male pattern baldness and prostate cancer risk in a population-based case–control study
- Formulation and optimization of folate-bovine serum albumin-coated ethoniosomes of pterostilbene as a targeted drug delivery system for lung cancer: In vitro and in vivo demonstrations
- lncRNAs UC.145 and PRKG1-AS1 Determine the Functional Output of DKK1 in Regulating the Wnt Signaling Pathway in Gastric Cancer
- Fabrication and in vitro evaluation of silk fibroin-folic acid decorated paclitaxel and hydroxyurea nanostructured lipid carriers for targeting ovarian cancer cells: A double sword approach
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- UP-02.010 Urinary PSA: Marker of Benign Prostatic Hyperplasia?
- 5-Alpha Reductase Inhibitor Use and Prostate Cancer Prevention: A Victim of the Times?
- H11 More cancer, better counting or better at diagnosis? The history of skin cancer registration
- Physician Awareness of the Safe Use of Cyproterone Acetate in Europe: A Survey on the Effectiveness of Additional Risk Minimization Measures
- Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
- ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
- TGF-β family signaling in stem cells
- Stretching the limits: from homeostasis to stem cell plasticity in wound healing and cancer
- The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model
- Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views
- Topical delivery of nanoemulsions for skin cancer treatment
- Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022
- Oxidative stress management in the hair follicle: Could targeting NRF2 counter age‐related hair disorders and beyond?
- High-confidence cancer patient stratification through multiomics investigation of DNA repair disorders
- Cancer risk in patients with alopecia areata: a nationwide population‐based matched cohort study
- An efficient, non-invasive approach for in-vivo sampling of hair follicles: design and applications in monitoring DNA damage and aging
- Zinc deficiency is associated with gynecologic cancer recurrence